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Abstract
Using the whole genome sequencing data and the simulated longitudinal phenotypes for 849 pedigree-based
individuals from Genetic Analysis Workshop 18, we investigated various approaches to detecting the association of
rare and common variants with blood pressure traits. We compared three strategies for longitudinal data: (a) using
the baseline measurement only, (b) using the average from multiple visits, and (c) using all individual
measurements. We also compared the power of using all of the pedigree-based data and the unrelated subset.
The analyses were performed without knowledge of the underlying simulating model.
Background
Whole genome sequencing (WGS) makes it possible for
investigators to extend association studies to rare var-
iants. Rare variants, which have minor allele frequencies
(MAFs) of less than 1% to 5%, might play an important
role in the etiology of complex traits and account for
missing heritability unexplained by common variants
[1-3]. However, traditional single-variant tests for com-
mon variants have limited power for testing rare variants
because of their low frequencies and large numbers. A
number of methods [4-7] have been developed to address
this challenge by jointly analyzing rare variants within a
region. Among these methods, the burden test of Lin and
Tang [7] easily fits into the regression framework that
can accommodate complex study designs and pheno-
types, thus remaining a competitive option.
The longitudinal study design, which collects repeated
measurements on the same subject over time, has been
routinely used in epidemiologic and clinical research.
The repeated measurements can reduce error and thus
increase statistical power compared with the single mea-
surement. There have been increasing applications of
such a design in genome-wide association studies
(GWAS) with a focus on common variants. The analyti-
cal strategies include using the measurement at a single
time point [8], using the summarized univariate measure-
ment [9] and adopting the linear mixed-effects model to
fully exploit information in the repeated measurements
[10,11]. However, the implementation of such designs is
limited in the context of WGS studies with a focus on
rare-variant associations.
In the era of next-generation sequencing studies, the
family-based design has the unique advantages of pro-
tecting against population stratification, detecting geno-
typing errors, and facilitating accurate imputation, all of
which are challenging issues to cope with in the studies
of rare variants using unrelated subjects. However, it is
well known that enrolling and sequencing additional
family members will not increase statistical power as
much as that can be achieved by the same number of
unrelated subjects. The degree of power gain from the
added family members depends on the extent of the
within-family correlation and the size of each family.
Thus, it is of interest to assess this power gain in each
specific study.
Genetic Analysis Workshop 18 (GAW18) provided
WGS data (sequencing plus imputation) in a pedigree-
based sample with longitudinal measurements for systolic
blood pressure (SBP) and diastolic blood pressure (DBP).
In this study, we implement methods to exploit longitu-
dinal and family structures and apply these methods to
examine the associations of aggregated rare variants, as
well as common single-nucleotide polymorphisms
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(SNPs), with SBP and DBP. We compare the power of
the methods using the baseline measurement only, using
the averaged value over repeated measurements, and
using the full information of longitudinal data. We also
contrast the power of the methods using all of the pedi-
gree-based data with that using the unrelated subset.
Methods
In this study, we focus on the first replicate of simulated
SBP and DBP and the genetic data from sequencing and
imputation only on chromosome 3 because of limited
computation resources. The analyses were performed
without knowledge of the underlying simulating model.
We obtained 849 individuals from 20 pedigrees, among
which 142 are unrelated. All individuals have SBP and
DBP measurements at three time points with no missing
data, as well as age, gender, smoking status, and antihy-
pertensive medication status. Note that we preadjust the
SBP and DBP measurements by the antihypertensive
medication status (i.e., increasing SBP by 10 mm Hg and
DBP by 5 mm Hg if the subject is taking medication).
We define common variants as those with MAFs 5% or
greater and obtain 403,098 SNPs on chromosome 3. We
jointly analyze rare variants by mRNA transcripts, which
are the functional products of genes. We exclude tran-
scripts whose total rare allele frequency (i.e., sum of
MAFs over all inclusive variants) is less than 0.01 and
end up with a total of 813 transcripts represented by
accession numbers. Given a common single-nucleotide
polymorphism (SNP) or a transcript for the phenotype,
we consider using (a) the baseline, (b) the time-averaged,
and (c) the repeated measurements; for study subjects,
we consider using (a) the entire pedigree-based sample
and (b) the unrelated subjects only. All statistical analyses
were carried out in R (http://www.r-project.org) version
2.15.1.
Notation
Assume there are m rare variants in a transcript. Under
the population-based design, let Yit denote the phenotype
measured for subject i at time t, Gi = (Gi1, Gi2, ..., Gim)
T
the genotypes of the m variants, and Xit = (Xit1, Xit2, ...,
Xitq)
T the q covariates including the intercept and possibly
time-varying ones. Under the family-based design and
when subject i belongs to family p, we modify the afore-
mentioned notation to be Ypit, Gpi and Xpit.
Burden score of rare variants
We focus on variants with MAF less than 5% and that
are putatively functional (i.e., nonsense, missense, or
splice site mutations). Specifically, using the chromoso-
mal location (NCBI built 37.1) provided by the GAW18
data, we search for functional annotation of 812,234
SNPs with MAFs 5% or less on chromosome 3 using
the GVS server (http://snp.gs.washington.edu). We con-
sider the following functional categories: missense, mis-
sense-near-splice, splice-3, splice-5, stop-gained, stop-
lost, and stop-lost-near-splice. Note that the functional
annotation is specific to each transcript. The burden
score of the ith subject at a given transcript is defined




In the framework of Lin and Tang [7], the burden
score is used in the following regression models as a
regular covariate.
Models and assumptions
Unrelated subjects with single measurements of blood
pressure
The single measurements of blood pressure can be the
baseline or time-averaged SBP or DBP. We denote the
baseline and averaged measurements by Yi1 and
Yi+ =
∑
tYit, respectively. Because they are all quantita-
tive, it is natural to relate each of them to Si and Xi
through the linear regression model:
Yi1 orYi+ = bSi + gTXi + ei, (1)
where i is an error term with mean zero and variance
σ 2 and Xi includes the intercept, gender, smoking status,
and baseline (averaged) age in the baseline (averaged)
phenotype model.
Unrelated subjects with repeated measurements of blood
pressure
To account for the correlation of measurements from
the same individual, we use the linear mixed-effects
model. For subject i at time t, it is written as
Yit = bSi + gTXit + bi + eit, (2)
where bi is a random effect that follows N(0, σ 2b ); it is
an error term that follows N(0, σ 2);it and bi are mutually
independent; and Xit consists of the intercept, gender,
smoking status, and the time-varying age. By including age
into Xit, we assume that the traits change linearly with
time. Both visual inspection of the individual-level trait
trajectories and statistical testing of the age coefficient
support the linear modeling (results not shown). Because
Cov (Yit,Yit ,) = σ 2b + σ
2 for t = t′ and Cov (Yit ,Yit ,) = σ 2b for t = t′,-




2) between any pair of measurements from
subject i. Note that bi is shared by different measurements
of subject i so that the induced correlations are the same.
Families with single measurements of blood pressure
To account for the phenotype correlation among sub-
jects from the same family, we also adopt a linear
mixed-effects model. For the ith subject in the pth pedi-
gree, we formulate that
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Ypi1 or Ypi+ = βSpi + γ TXpi + gpi + pi, (3)
where gpi is a random effect representing genetic simi-
larity among family members, pi is an error term that
follows N(0, σ 2), gpi is independent of pi pi, and Xpi is
the same as Xi in (1). In addition, we assume that
Corr(gpi, gpi, ) = 2ψii, Corr(gpi, gpi, ) = 2ψii,, where ψii, is
the kinship coefficient between family member i and i’.
Unlike bi in (2), which is shared among correlated units
(time), there is a random effect gpi for each unit (sub-
ject) here, and their covariance matrix is specified so
that correlations among different pairs of family mem-
bers are different.
Families with repeated measurements of blood pressure
Model (3) can be readily extended to accommodate
repeated measurements. We include the repeated mea-
surements in (3) as follows:
Ypit = βSpi + γ TXpit + gpi + bpi + pit , (4)
where Xpit contains the time-varying age, gpi is intro-
duced previously, bpi follows the same distribution as bi
in model (2), and gpi and bpi are independent of each
other. Unlike in (2), bpi here characterizes the additional
correlation between repeated measurements after adjust-
ing for the genetically induced portion. To see this, we
consider the reduced model without bi:
Ypit = βSpi + γ TXpit + gpi + pit (5)
For both (4) and (5), the covariance between different




= 2ψii, σ 2g for any t
and t’. However, the covariance between measurements
(t = t′) from the same subject is Cov (Ypit ,Ypit ,
)
= σ 2g + σ
2
b




= σ 2g based on (5).
Although model (4) is more flexible than (5), the
chromosome-wide scan based on (4) is not feasible
within the given timeframe and available computational
resources. We thus adopt a two-stage strategy that first
scans chromosome 3 using (5) and then refines the
p-values of top SNPs using (4).
Population stratification
GAW18 data consist of Mexican Americans from San
Antonio, a population that may have an admixed ances-
try of whites and Native Americans. To account for pos-
sible population stratification, we include top principal
components (PCs) of SNP genotypes as covariates in the
above regression models. We first obtain independent
SNPs (linkage disequilibrium R2 <0.2) restricted to those
with MAFs 5% or greater using the unrelated subjects.
Then we project the SNP loadings of unrelated subjects
to their relatives to calculate the eigenvectors of the
entire sample of families.
Results
Figure 1 displays the quantile-quantile (QQ) plots of
p-values for testing the association between common
SNPs and SBP. All 6 tests produced proper type I error
because their genomic control parameter λ′s are close to
1. This suggests that the data are well described by our
models and population stratification is appropriately
adjusted by the PCs. Clearly, using all pedigree-based
samples is substantially more powerful than using the
unrelated subjects only. In addition, using the averaged
SBP yielded smaller p-values for top SNPs than using
the baseline or repeated measurements, and using the
repeated measurements is slightly more powerful than
using the baseline. This pattern can also be seen in
Figure 2. The top five SNPs based on the method using
the averaged SBP and all subjects are listed in Table 1,
whose last column provides the refined p-values from
model (4). Note that the use of model (4) does not alter
the aforementioned order based on power, although it
tends to slightly improve on the use of model (5). Using
the Bonferroni correction, the genome-wide significance
threshold is 1.3 × 10-7, at which the top five SNPs can
be declared as genome-wide significant by any method.
Note that we only focused on chromosome 3, so what
we are assessing is in fact chromosome-wide signifi-
cance. For testing the association between rare variants
and SBP, the 6 tests also have controlled type I error
(see Figure 3 for QQ plots of p-values). Again, com-
pared with the unrelated subset, the relatives added con-
siderable information on the associations of the top three
transcripts. All three types of SBP generated comparable
power with all individuals, and the three consensus top
transcripts are described in Table 2. Using the Bonferroni
correction, the genome-wide significance threshold is
6.2 × 10-5, at which the three top transcripts can be
declared as genome-wide significant by any method. All
of the identified common and rare variants map to the
gene MAP4, which spans from 47,892,180 to 48,130,769
on chromosome 3.
The results of testing the genetic association with DBP
show similar patterns as with SBP (data not shown). In
particular, using the averaged DBP yielded better power
than using the repeated measurements. Tables 1 and 2 pro-
vide the top common SNPs and transcripts, respectively.
Discussion and conclusions
We investigated three approaches to exploiting longitu-
dinal phenotype data and assessed the power gain of
adding family members in the context of WGS studies.
Most GWAS have focused on the population-based
design, which maximizes the power per genotyped sub-
ject. Our results demonstrated that including family
members can also significantly boost the power. Most
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Figure 1 Quantile-quantile plots of p-values for tests between common single-nucleotide polymorphisms and systolic blood pressure
(SBP)
Figure 2 Count of tests with p-values lower than the p-value threshold across a range of p-value cutoffs
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Table 1 p-Values for the top five common single-nucleotide polymorphisms based on the analysis of averaged systolic
blood pressure
SBP p-values
SNP ID Gene Chr Position MAF Baseline Averaged Repeated-1 Repeated-2
3_47903424 MAP4 3 47903424 0.124 2.3 × 10-9 6.3 × 10-11 2.2 × 10-9 1.1 × 10-10
3_47903305 MAP4 3 47903305 0.123 3.2 × 10-9 6.5 × 10-11 1.7 × 10-9 1.0 × 10-10
3_47905079 MAP4 3 47905079 0.124 3.2 × 10-9 6.5 × 10-11 1.7 × 10-9 1.0 × 10-10
3_47588649 MAP4 3 47588649 0.122 3.5 × 10-9 6.7 × 10-11 1.8 × 10-9 1.1 × 10-10
3_47990500 MAP4 3 47990500 0.123 3.6 × 10-9 7.2 × 10-11 2.1 × 10-9 1.1 × 10-10
DBP p-values
SNP ID Gene Chr Position MAF Baseline Averaged Repeated-1 Repeated-2
3_48064367 MAP4 3 48064367 0.128 1.4 × 10-11 3.6 × 10-13 3.5 × 10-13 3.6 × 10-13
3_47711490 MAP4 3 47711490 0.120 1.8 × 10-11 3.9 × 10-13 5.4 × 10-12 3.9 × 10-13
3_48092335 MAP4 3 48092335 0.127 2.8 × 10-11 4.8 × 10-13 2.2 × 10-12 5.2 × 10-13
3_48105528 MAP4 3 48105528 0.127 2.8 × 10-11 4.8 × 10-13 2.2 × 10-12 5.2 × 10-13
3_47990500 MAP4 3 47990500 0.123 4.9 × 10-11 5.0 × 10-13 5.8 × 10-12 5.4 × 10-13
Note: Repeated-1 and repeated-2 correspond to model (5) and model (4), respectively.
DBP, diastolic blood pressure; MAF, minor allele frequency; SBP, systolic blood pressure
Figure 3 Quantile-quantile plots of p-values for tests between common single-nucleotide polymorphisms and systolic blood pressure
(SBP)
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GWAS have ignored the longitudinal nature of the pheno-
type data, which are available from many prospective
cohorts. The use of the longitudinal data can provide a
more accurate measurement of the phenotype and thus
serves as a powerful tool in genetic association studies.
With more clinic data being available through the electro-
nic medical record (EMR) system and more clinic popula-
tions with genotypic data, the search for disease-associated
common and rare variants can be more fruitful by improv-
ing the phenotyping via longitudinal information.
It appears somewhat counterintuitive that using the
time-averaged measurement is more powerful than using
the repeated measurement in the analysis of the GAW18
data. This is possible because, in the presence of linear
time effect, the averaged measurement does not lose any
information compared with the repeated measurements
but simply reduces error. When more complex longitudi-
nal structures exist, the repeated measurements retain
full information and are expected to outperform the aver-
aged measurement.
A family-based design can allow us to test association
and linkage simultaneously. In this paper, we focused on
the association analysis only. We modeled the associa-
tion in the fixed-effect parameters and accounted for
family relatedness using the random-effect parameters,
whose covariances among family members are formu-
lated through the kinship coefficient. Our models can be
readily extended to linkage analysis by including another
set of random-effect parameters whose covariances
depend on the proportion of alleles shared identical by
descent at the marker locus between a relative pair [12].
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